Drug intelligence / Profile preview

karyocyte scavenger

Development stage: Preclinical
Lead developer: The health ministry technology JiaoYuSi key projects (201002005)

Overview

Karyocyte scavenger is an intervention developed by The health ministry technology JiaoYuSi key projects (201002005) and West China Hospital, Sichuan University. It is being investigated for its safety in intraoperative blood salvage during oncosurgery for cancer. The intervention aims to remove karyocytes, which are nucleated cells, from the blood, likely to prevent the re-transfusion of cancer cells to the patient during surgery.

Other names: karyocyte scavenger

Beyond the preview

Go deeper on karyocyte scavenger.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on karyocyte scavenger.

Explore the full profile